Study on Bladder & Sexual Function Change After Simple Hysterectomy

See also
Status	Clinical Trial	Phase
Completed	`NCT01893086` - Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy	Phase 3
Completed	`NCT01880710` - Total Versus Subtotal Abdominal Hysterectomy	N/A
Completed	`NCT01217866` - A Retrospective Review of Enseal Laparoscopic Vaginal Assisted Hysterectomy (LAVH) Versus Traditional LAVH	N/A
Completed	`NCT01861067` - LESS-TLH Versus LESS-LAVH	Phase 3

See also

Status

Clinical Trial

Phase

Completed

NCT01893086 - Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy

Phase 3

Completed

NCT01880710 - Total Versus Subtotal Abdominal Hysterectomy

N/A

Completed

NCT01217866 - A Retrospective Review of Enseal Laparoscopic Vaginal Assisted Hysterectomy (LAVH) Versus Traditional LAVH

N/A

Completed

NCT01861067 - LESS-TLH Versus LESS-LAVH

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01683890
Study type	Observational
Source	Asan Medical Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	September 2012
Completion date	July 2017

Study on Bladder and Sexual Function Change After Simple Hysterectomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms